-
1
-
-
0021226066
-
Histopathologic prognostic factors in neuroblastic tumours: Definition of subtypes of gaglioneuroblastoma and an age-linked classification of neuroblastomas
-
Shimada H, Chatten J, Newton WA Jr, et al. Histopathologic prognostic factors in neuroblastic tumours: definition of subtypes of gaglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73:405-16.
-
(1984)
J Natl Cancer Inst
, vol.73
, pp. 405-416
-
-
Shimada, H.1
Chatten, J.2
Newton Jr, W.A.3
-
2
-
-
0033565765
-
The International Neuroblastoma Pathology Classification (the Shimada system)
-
Shimada H, Ambros IM, Dehner LP, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999; 86:364-72.
-
(1999)
Cancer
, vol.86
, pp. 364-372
-
-
Shimada, H.1
Ambros, I.M.2
Dehner, L.P.3
-
3
-
-
12744262848
-
The biologic basis for neuroblastoma heterogeneity and risk stratification
-
Maris JM. The biologic basis for neuroblastoma heterogeneity and risk stratification. Curr Opin Pediatr 2005; 17:7-13.
-
(2005)
Curr Opin Pediatr
, vol.17
, pp. 7-13
-
-
Maris, J.M.1
-
4
-
-
0035889955
-
Histology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumours: A report from the Children's Cancer Group
-
Goto S, Umehara S, Gerbing RB, et al. Histology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumours: a report from the Children's Cancer Group. Cancer 2001; 92:2699-708.
-
(2001)
Cancer
, vol.92
, pp. 2699-2708
-
-
Goto, S.1
Umehara, S.2
Gerbing, R.B.3
-
5
-
-
0033600283
-
Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma
-
Bown N, Cotterill S, Lastowska M, et al. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999; 340:1954-61.
-
(1999)
N Engl J Med
, vol.340
, pp. 1954-1961
-
-
Bown, N.1
Cotterill, S.2
Lastowska, M.3
-
6
-
-
0029121989
-
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis
-
Shimada H, Stram DO, Chatten J, et al. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 1995; 87:1470-6.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 1470-1476
-
-
Shimada, H.1
Stram, D.O.2
Chatten, J.3
-
7
-
-
33845939529
-
Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma
-
Altungoz O, Aygun N, Tumer S, et al. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma. Cancer Genet Cytogenet 2007; 172:113-9.
-
(2007)
Cancer Genet Cytogenet
, vol.172
, pp. 113-119
-
-
Altungoz, O.1
Aygun, N.2
Tumer, S.3
-
8
-
-
0001083469
-
Neuroblastic tumors of adrenal gland and sympathetic nervous system
-
Kleihues P, Cavenee WK, eds, 2nd ed. Lyon: IARC Press
-
Schwab M, Shimada H, Joshi V, Brodeur GM. Neuroblastic tumors of adrenal gland and sympathetic nervous system. In: Kleihues P, Cavenee WK, eds. Pathology and Genetics of Tumours of the Nervous System. 2nd ed. Lyon: IARC Press, 2000: 153-61.
-
(2000)
Pathology and Genetics of Tumours of the Nervous System
, pp. 153-161
-
-
Schwab, M.1
Shimada, H.2
Joshi, V.3
Brodeur, G.M.4
-
9
-
-
0003484109
-
-
Brodeur GM, Sawada T, Tsuchida Y, et al, eds, 1st ed. Amsterdam: Elsevier Science BV
-
Brodeur GM, Sawada T, Tsuchida Y, et al, eds. Neuroblastoma. 1st ed. Amsterdam: Elsevier Science BV, 2000.
-
(2000)
Neuroblastoma
-
-
-
10
-
-
0037601662
-
Quality assessment of genetic markers used for therapy stratification
-
Ambros IM, Benard J, Boavida M, et al. Quality assessment of genetic markers used for therapy stratification. J Clin Oncol 2003; 21:2077-84.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2077-2084
-
-
Ambros, I.M.1
Benard, J.2
Boavida, M.3
-
11
-
-
0034061843
-
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study
-
Schmidt ML, Lukens JN, Seeger RC, et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol 2000; 18:1260-8.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1260-1268
-
-
Schmidt, M.L.1
Lukens, J.N.2
Seeger, R.C.3
-
12
-
-
33750325100
-
Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study
-
Moreau LA, McGrady P, London WB, et al. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study. Clin Cancer Res 2006; 12:5693-7.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 5693-5697
-
-
Moreau, L.A.1
McGrady, P.2
London, W.B.3
-
13
-
-
0034928910
-
Genetic heterogeneity and clonal evolution in neuroblastoma
-
Mora J, Cheung NK, Gerald WL. Genetic heterogeneity and clonal evolution in neuroblastoma. Br J Cancer 2001; 85:182-9.
-
(2001)
Br J Cancer
, vol.85
, pp. 182-189
-
-
Mora, J.1
Cheung, N.K.2
Gerald, W.L.3
-
14
-
-
0035677931
-
Neuroblastoma tumour genetics: Clinical and biological aspects
-
Bown N. Neuroblastoma tumour genetics: clinical and biological aspects. J Clin Pathol 2001; 54:897-910.
-
(2001)
J Clin Pathol
, vol.54
, pp. 897-910
-
-
Bown, N.1
-
15
-
-
0028944776
-
Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma
-
Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995; 24:215-21.
-
(1995)
Med Pediatr Oncol
, vol.24
, pp. 215-221
-
-
Caron, H.1
-
16
-
-
0031409099
-
Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. UK Children's Cancer Study Group and the UK Cancer Cytogenetics Group
-
Lastowska M, Cotterill S, Pearson AD, et al. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. UK Children's Cancer Study Group and the UK Cancer Cytogenetics Group. Eur J Cancer 1997; 33:1627-33.
-
(1997)
Eur J Cancer
, vol.33
, pp. 1627-1633
-
-
Lastowska, M.1
Cotterill, S.2
Pearson, A.D.3
-
17
-
-
0033732678
-
Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status
-
Cunsolo CL, Bicocchi MP, Petti AR, Tonini GP. Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status. Br J Cancer 2000; 83:1295-300.
-
(2000)
Br J Cancer
, vol.83
, pp. 1295-1300
-
-
Cunsolo, C.L.1
Bicocchi, M.P.2
Petti, A.R.3
Tonini, G.P.4
-
18
-
-
13344275864
-
Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
-
Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 1996; 334:225-30.
-
(1996)
N Engl J Med
, vol.334
, pp. 225-230
-
-
Caron, H.1
van Sluis, P.2
de Kraker, J.3
-
19
-
-
0034015079
-
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A Children's Cancer Group Study
-
Maris JM, Weiss MJ, Guo C, et al. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group Study. J Clin Oncol 2000; 18:1888-99.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1888-1899
-
-
Maris, J.M.1
Weiss, M.J.2
Guo, C.3
-
20
-
-
0036115740
-
Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations
-
Splitz R, Hero B, Westermann F, et al. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations. Genes Chromosomes Cancer 2002; 34:299-305.
-
(2002)
Genes Chromosomes Cancer
, vol.34
, pp. 299-305
-
-
Splitz, R.1
Hero, B.2
Westermann, F.3
-
21
-
-
28144453057
-
Chromosome 1p and 11q deletions and outcome in neuroblastoma
-
Attiyeh EF, London WB, Mosse YP, et al. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 2005; 353:2243-53.
-
(2005)
N Engl J Med
, vol.353
, pp. 2243-2253
-
-
Attiyeh, E.F.1
London, W.B.2
Mosse, Y.P.3
-
23
-
-
0034598797
-
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
-
Islam A, Kageyama H, Takada N, et al. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 2000; 19:617-23.
-
(2000)
Oncogene
, vol.19
, pp. 617-623
-
-
Islam, A.1
Kageyama, H.2
Takada, N.3
-
24
-
-
85047695614
-
-
Godfried MB, Veenstra M, v Sluis P, et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 2002; 21:2097-101.
-
Godfried MB, Veenstra M, v Sluis P, et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 2002; 21:2097-101.
-
-
-
-
25
-
-
38749131235
-
Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics
-
Vandesompele J, Michels E, De Preter K, et al. Identification of 2 putative critical segments of 17q gain in neuroblastoma through integrative genomics. Int J Cancer 2008; 122:1177-82.
-
(2008)
Int J Cancer
, vol.122
, pp. 1177-1182
-
-
Vandesompele, J.1
Michels, E.2
De Preter, K.3
-
26
-
-
0037446975
-
PPM1D is a potential target for 17q gain in neuroblastoma
-
Saito-Ohara F, Imoto I, Inoue J, et al. PPM1D is a potential target for 17q gain in neuroblastoma. Cancer Res 2003; 63:1876-83.
-
(2003)
Cancer Res
, vol.63
, pp. 1876-1883
-
-
Saito-Ohara, F.1
Imoto, I.2
Inoue, J.3
-
27
-
-
0036752748
-
Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: Are they secondary events?
-
Trakhtenbrot L, Cohen N, Betts DR, et al. Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: are they secondary events? Cancer Genet Cytogenet 2002; 137:95-101.
-
(2002)
Cancer Genet Cytogenet
, vol.137
, pp. 95-101
-
-
Trakhtenbrot, L.1
Cohen, N.2
Betts, D.R.3
-
28
-
-
10944248244
-
New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status
-
Simon T, Spitz R, Faldum A, Hero B, Berthold F. New definition of low-risk neuroblastoma using stage, age, and 1p and MYCN status. J Pediatr Hematol Oncol 2004; 26:791-6.
-
(2004)
J Pediatr Hematol Oncol
, vol.26
, pp. 791-796
-
-
Simon, T.1
Spitz, R.2
Faldum, A.3
Hero, B.4
Berthold, F.5
-
29
-
-
3543023204
-
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
-
Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30:e57
-
(2002)
Nucleic Acids Res
, vol.30
-
-
Schouten, J.P.1
McElgunn, C.J.2
Waaijer, R.3
|